{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T06:27:58Z","timestamp":1790836078356,"version":"4.1.0"},"reference-count":63,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,2,17]],"date-time":"2022-02-17T00:00:00Z","timestamp":1645056000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100012166","name":"National Key Research and Development Program of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002726","name":"Beijing Normal University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002726","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008235","name":"Peking Union Medical College Hospital","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100008235","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Mol. Biosci."],"abstract":"<jats:p>Vitiligo is a common acquired skin disorder caused by immune-mediated destruction of epidermal melanocytes. Systemic glucocorticoids (GCs) have been used to prevent the progression of active vitiligo, with 8.2\u201356.2% of patients insensitive to this therapy. Currently, there is a lack of biomarkers that can accurately predict and evaluate treatment responses. The goal of this study was to identify candidate urinary protein biomarkers to predict the efficacy of GCs treatment in active vitiligo patients and monitor the disease. Fifty-eight non-segmental vitiligo patients were enrolled, and 116 urine samples were collected before and after GCs treatment. Patients were classified into a treatment-effective group (<jats:italic>n<\/jats:italic>= 42) and a treatment-resistant group (<jats:italic>n<\/jats:italic>= 16). Each group was divided equally into age- and sex-matched experimental and validation groups, and proteomic analyses were performed. Differentially expressed proteins were identified, and Ingenuity Pathway Analysis was conducted for the functional annotation of these proteins. Receiver operating characteristic curves were used to evaluate the diagnostic value. A total of 245 and 341 differentially expressed proteins between the treatment-resistant and treatment-effective groups were found before and after GCs treatment, respectively. Bioinformatic analysis revealed that the urinary proteome reflected the efficacy of GCs in active vitiligo patients. Eighty and fifty-four candidate biomarkers for treatment response prediction and treatment response evaluation were validated, respectively. By ELISA analysis, retinol binding protein-1 and torsin 1A interacting protein 1 were validated to have the potential to predict the efficacy of GCs with AUC value of 1 and 0.875, respectively. Retinol binding protein-1, torsin 1A interacting protein 1 and protein disulfide-isomerase A4 were validated to have the potential to reflect positive treatment effect to GCs treatment in active vitiligo with AUC value of 0.861, 1 and 0.868, respectively. This report is the first to identify urine biomarkers for GCs treatment efficacy prediction in vitiligo patients. These findings might contribute to the application of GCs in treating active vitiligo patients.<\/jats:p>","DOI":"10.3389\/fmolb.2022.761562","type":"journal-article","created":{"date-parts":[[2022,2,17]],"date-time":"2022-02-17T04:32:41Z","timestamp":1645072361000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":15,"title":["Urinary Proteomics Analysis of Active Vitiligo Patients: Biomarkers for Steroid Treatment Efficacy Prediction and Monitoring"],"prefix":"10.3389","volume":"9","author":[{"given":"Yue-Tong","family":"Qian","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao-Yan","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hai-Dan","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ji-Yu","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jia-Meng","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tian","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jia-Wei","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Tan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dong-Lai","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2022,2,17]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1378\/chest.08-0440","article-title":"Molecular Mechanisms of Corticosteroid Resistance","volume":"134","author":"Adcock","year":"2008","journal-title":"Chest"},{"key":"B2","doi-asserted-by":"publisher","first-page":"27147","DOI":"10.1074\/jbc.M116.754887","article-title":"Targeted Elimination of G Proteins and Arrestins Defines Their Specific Contributions to Both Intensity and Duration of G Protein-Coupled Receptor Signaling","volume":"291","author":"Alvarez-Curto","year":"2016","journal-title":"J. Biol. Chem."},{"key":"B3","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1097\/00008571-200011000-00006","article-title":"Polymorphisms within Glutathione S-Transferase Genes and Initial Response to Glucocorticoids in Childhood Acute Lymphoblastic Leukaemia","volume":"10","author":"Anderer","year":"2000","journal-title":"Pharmacogenetics"},{"key":"B4","doi-asserted-by":"publisher","first-page":"2700","DOI":"10.1210\/en.2008-1618","article-title":"Retinoic Acid Reduces Glucocorticoid Sensitivity in C2C12 Myotubes by Decreasing 11\u03b2-Hydroxysteroid Dehydrogenase Type 1 and Glucocorticoid Receptor Activities","volume":"150","author":"Aubry","year":"2009","journal-title":"Endocrinology"},{"key":"B5","doi-asserted-by":"publisher","first-page":"1905","DOI":"10.1016\/S0140-6736(09)60326-3","article-title":"Glucocorticoid Resistance in Inflammatory Diseases","volume":"373","author":"Barnes","year":"2009","journal-title":"The Lancet"},{"key":"B6","doi-asserted-by":"publisher","first-page":"1062","DOI":"10.1210\/mend.15.7.0657","article-title":"Interleukin-2 Inhibits Glucocorticoid Receptor Transcriptional Activity through a Mechanism Involving STAT5 (Signal Transducer and Activator of Transcription 5) but Not AP-1","volume":"15","author":"Biola","year":"2001","journal-title":"Mol. Endocrinol."},{"key":"B7","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1007\/s12016-017-8622-7","article-title":"Vitiligo: Focus on Clinical Aspects, Immunopathogenesis, and Therapy","volume":"54","author":"Boniface","year":"2018","journal-title":"Clinic Rev. Allerg Immunol."},{"key":"B8","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1165\/rcmb.2011-0364OC","article-title":"Cytokines Alter Glucocorticoid Receptor Phosphorylation in Airway Cells","volume":"47","author":"Bouazza","year":"2012","journal-title":"Am. J. Respir. Cel Mol Biol"},{"key":"B9","doi-asserted-by":"publisher","first-page":"e13669","DOI":"10.14814\/phy2.13669","article-title":"Molecular Changes during TGF\u03b2 -mediated Lung Fibroblast-Myofibroblast Differentiation: Implication for Glucocorticoid Resistance","volume":"6","author":"Breton","year":"2018","journal-title":"Physiol. Rep."},{"key":"B10","doi-asserted-by":"publisher","first-page":"L71","DOI":"10.1152\/ajplung.00547.2017","article-title":"Th1 Cytokines TNF-\u03b1 and IFN-\u03b3 Promote Corticosteroid Resistance in Developing Human Airway Smooth Muscle","volume":"316","author":"Britt","year":"2019","journal-title":"Am. J. Physiology-Lung Cell Mol. PhysiologyAm J Physiol Lung Cel Mol Physiol"},{"key":"B11","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1021\/pr050300l","article-title":"Normalization Approaches for Removing Systematic Biases Associated with Mass Spectrometry and Label-free Proteomics","volume":"5","author":"Callister","year":"2006","journal-title":"J. Proteome Res."},{"key":"B12","doi-asserted-by":"publisher","first-page":"2299","DOI":"10.1007\/s00467-013-2569-6","article-title":"Urinary Low-Molecular-Weight Protein Excretion in Pediatric Idiopathic Nephrotic Syndrome","volume":"28","author":"Chehade","year":"2013","journal-title":"Pediatr. Nephrol."},{"key":"B13","doi-asserted-by":"publisher","first-page":"1141","DOI":"10.3390\/ijms20051141","article-title":"Proteomics in Psoriasis","volume":"20","author":"Chularojanamontri","year":"2019","journal-title":"Ijms"},{"key":"B14","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1111\/ijd.12642","article-title":"Systemic Glucocorticoids: Important Issues and Practical Guidelines for the Dermatologist","volume":"54","author":"Dodiuk-Gad","year":"2015","journal-title":"Int. J. Dermatol."},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1007\/s00403-021-02228-9","article-title":"Systemic CXCL10 Is a Predictive Biomarker of Vitiligo Lesional Skin Infiltration, PUVA, NB-UVB and Corticosteroid Treatment Response and Outcome","author":"El-Domyati","year":"2021","journal-title":"Arch. Dermatol. Res."},{"key":"B16","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1093\/jnci\/dji004","article-title":"Cellular Retinol-Binding Protein I, a Regulator of Breast Epithelial Retinoic Acid Receptor Activity, Cell Differentiation, and Tumorigenicity","volume":"97","author":"Farias","year":"2005","journal-title":"JNCI J. Natl. Cancer Inst."},{"key":"B17","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1677\/joe.0.1780339","article-title":"Glucocorticoid Resistance in Inflammatory Bowel Disease","volume":"178","author":"Farrell","year":"2003","journal-title":"J. Endocrinol."},{"key":"B18","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1165\/rcmb.2007-0327OC","article-title":"IFN-\u03b3 Reverses IL-2- and IL-4-Mediated T-Cell Steroid Resistance","volume":"40","author":"Goleva","year":"2009","journal-title":"Am. J. Respir. Cel Mol Biol"},{"key":"B19","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1186\/s12967-015-0712-9","article-title":"Differential Urinary Glycoproteome Analysis of Type 2 Diabetic Nephropathy Using 2D-LC-MS\/MS and iTRAQ Quantification","volume":"13","author":"Guo","year":"2015","journal-title":"J. Transl Med."},{"key":"B20","doi-asserted-by":"publisher","first-page":"14789","DOI":"10.1073\/pnas.0409904102","article-title":"Profiling of Genes Expressed in Peripheral Blood Mononuclear Cells Predicts Glucocorticoid Sensitivity in Asthma Patients","volume":"102","author":"Hakonarson","year":"2005","journal-title":"Proc. Natl. Acad. Sci."},{"key":"B21","doi-asserted-by":"publisher","first-page":"103832","DOI":"10.1016\/j.jprot.2020.103832","article-title":"Urinary Protein Biomarkers for Pediatric Medulloblastoma","volume":"225","author":"Hao","year":"2020","journal-title":"J. Proteomics"},{"key":"B22","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1016\/j.pharmthera.2016.06.002","article-title":"Glucocorticoid-independent Modulation of GR Activity: Implications for Immunotherapy","volume":"165","author":"Hapgood","year":"2016","journal-title":"Pharmacol. Ther."},{"key":"B23","doi-asserted-by":"publisher","first-page":"a022061","DOI":"10.1101\/cshperspect.a022061","article-title":"TGF-\u03b2 Signaling from Receptors to Smads","volume":"8","author":"Hata","year":"2016","journal-title":"Cold Spring Harb Perspect. Biol."},{"key":"B24","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/s0923-1811(99)00035-3","article-title":"The Changes of Serum Soluble Intercellular Adhesion Molecule-1 after Systemic Steroid Treatment in Vitiligo","volume":"22","author":"Hwan Hwang","year":"1999","journal-title":"J. Dermatol. Sci."},{"key":"B25","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2016\/9602472","article-title":"Proteomic Approaches to Biomarker Discovery in Cutaneous T-Cell Lymphoma","volume":"2016","author":"Ion","year":"2016","journal-title":"Dis. Markers"},{"key":"B26","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1684\/ejd.2012.1742","article-title":"Decline of Disease Activity and Autoantibodies to Desmoglein 3 and Envoplakin by Oral Prednisolone in Paraneoplastic Pemphigus with Benign Thymoma","volume":"22","author":"Ishii","year":"2012","journal-title":"Eur. J. Dermatol."},{"key":"B27","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1111\/j.1529-8019.2007.00133.x","article-title":"Update on the Dermatologic Use of Systemic Glucocorticosteroids","volume":"20","author":"Jackson","year":"2007","journal-title":"Dermatol. Ther."},{"key":"B28","doi-asserted-by":"crossref","first-page":"3460","DOI":"10.4049\/jimmunol.151.7.3460","article-title":"Combination IL-2 and IL-4 Reduces Glucocorticoid Receptor-Binding Affinity and T Cell Response to Glucocorticoids","volume":"151","author":"Kam","year":"1993","journal-title":"J. Immunol."},{"key":"B29","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1002\/iid3.249","article-title":"IL\u20102 Modulates Th2 Cell Responses to Glucocorticosteroid: A Cause of Persistent Type 2 Inflammation?","volume":"7","author":"Kanagalingam","year":"2019","journal-title":"Immun. Inflamm. Dis."},{"key":"B30","doi-asserted-by":"publisher","first-page":"259","DOI":"10.2310\/7750.2013.12053","article-title":"Low-dose Oral Mini-Pulse Dexamethasone Therapy in Progressive Unstable Vitiligo","volume":"17","author":"Kanwar","year":"2013","journal-title":"J. Cutan. Med. Surg."},{"key":"B31","doi-asserted-by":"publisher","first-page":"652824","DOI":"10.3389\/fmed.2021.652824","article-title":"Different Biological Pathways between Good and Poor Inhaled Corticosteroid Responses in Asthma","volume":"8","author":"Kim","year":"2021","journal-title":"Front. Med."},{"key":"B32","doi-asserted-by":"publisher","first-page":"885","DOI":"10.1083\/jcb.200409150","article-title":"G Protein \u03b2 Interacts with the Glucocorticoid Receptor and Suppresses its Transcriptional Activity in the Nucleus","volume":"169","author":"Kino","year":"2005","journal-title":"J. Cel Biol"},{"key":"B33","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1111\/bjd.13531","article-title":"Vitiligo Assessment Methods - Vitiligo Area Scoring Index and Vitiligo European Task Force Assessment","volume":"172","author":"Kohli","year":"2015","journal-title":"Br. J. Dermatol."},{"key":"B34","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1016\/s0960-0760(02)00223-6","article-title":"Signal Transducer and Activator of Transcription-3 and Phosphatidylinositol-3 Kinase as Coordinate Regulators of Melanoma Cell Response to Glucocorticoid Hormones","volume":"82","author":"Krasil'nikov","year":"2002","journal-title":"J. Steroid Biochem. Mol. Biol."},{"key":"B35","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1084\/jem.181.1.33","article-title":"Dysregulation of Interleukin 4, Interleukin 5, and Interferon Gamma Gene Expression in Steroid-Resistant Asthma","volume":"181","author":"Leung","year":"1995","journal-title":"J. Exp. Med."},{"key":"B36","doi-asserted-by":"publisher","first-page":"480","DOI":"10.4103\/0366-6999.225055","article-title":"Proteomic Analysis of the Serum of Patients with Stable Vitiligo and Progressive Vitiligo","volume":"131","author":"Li","year":"2018","journal-title":"Chin. Med. J. (Engl)."},{"key":"B37","doi-asserted-by":"publisher","first-page":"2651","DOI":"10.3892\/mmr.2017.8159","article-title":"Screening and Identification of Differentially Expressed Serum Proteins in Patients with Vitiligo Using Two-dimensional G-el Electrophoresis Coupled with Mass Spectrometry","volume":"17","author":"Li","year":"2018","journal-title":"Mol. Med. Rep."},{"key":"B38","doi-asserted-by":"publisher","first-page":"e216","DOI":"10.1111\/ced.13961","article-title":"Comprehensive Lipidomic, Metabolomic and Proteomic Profiling Reveals the Role of Immune System in Vitiligo","volume":"44","author":"Liang","year":"2019","journal-title":"Clin. Exp. Dermatol."},{"key":"B39","doi-asserted-by":"publisher","first-page":"17989","DOI":"10.1038\/s41598-020-75135-0","article-title":"Urinary Metabolomic Investigations in Vitiligo Patients","volume":"10","author":"Liu","year":"2020","journal-title":"Sci. Rep."},{"key":"B40","doi-asserted-by":"publisher","first-page":"3105","DOI":"10.1002\/pmic.201200125","article-title":"Proteomic Analysis of Cerebrospinal Fluid before and after Intrathecal Injection of Steroid into Patients with Postherpetic Pain","volume":"12","author":"Lu","year":"2012","journal-title":"Proteomics"},{"key":"B41","doi-asserted-by":"publisher","first-page":"809","DOI":"10.1097\/SLA.0b013e31823699f2","article-title":"Serum Proteomic Profiling Reveals that Pretreatment Complement Protein Levels Are Predictive of Esophageal Cancer Patient Response to Neoadjuvant Chemoradiation","volume":"254","author":"Maher","year":"2011","journal-title":"Ann. Surg."},{"key":"B42","first-page":"1487","article-title":"Raised Intracellular Glutathione Levels Correlate with In Vitro Resistance to Cytotoxic Drugs in Leukaemic Cells from Patients with Acute Lymphoblastic Leukemia","volume":"8","author":"Maung","year":"1994","journal-title":"Leukemia"},{"key":"B43","doi-asserted-by":"publisher","first-page":"617937","DOI":"10.3389\/fonc.2021.617937","article-title":"Overcoming Glucocorticoid Resistance in Acute Lymphoblastic Leukemia: Repurposed Drugs Can Improve the Protocol","volume":"11","author":"Olivas-Aguirre","year":"2021","journal-title":"Front. Oncol."},{"key":"B44","doi-asserted-by":"publisher","first-page":"753","DOI":"10.1111\/j.1365-4362.1993.tb02754.x","article-title":"Oral Mini-Pulse Therapy with Betamethasone in Vitiligo Patients Having Extensive or Fast-Spreading Disease","volume":"32","author":"Pasricha","year":"1993","journal-title":"Int. J. Dermatol."},{"key":"B45","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1128\/MMBR.00064-15","article-title":"The Interactome of the Glucocorticoid Receptor and its Influence on the Actions of Glucocorticoids in Combatting Inflammatory and Infectious Diseases","volume":"80","author":"Petta","year":"2016","journal-title":"Microbiol. Mol. Biol. Rev."},{"key":"B46","doi-asserted-by":"publisher","first-page":"997","DOI":"10.1080\/14789450.2017.1388166","article-title":"Application of Proteomics to Graft-Versus-Host Disease: from Biomarker Discovery to Potential Clinical Applications","volume":"14","author":"Presland","year":"2017","journal-title":"Expert Rev. Proteomics"},{"key":"B47","doi-asserted-by":"publisher","first-page":"814","DOI":"10.1067\/mjd.2001.113475","article-title":"Oral Dexamethasone Pulse Treatment for Vitiligo","volume":"44","author":"Radakovic-Fijan","year":"2001","journal-title":"J. Am. Acad. Dermatol."},{"key":"B48","doi-asserted-by":"publisher","first-page":"2580","DOI":"10.1016\/j.biocel.2013.08.018","article-title":"The NF-\u039ab Signalling Pathway in Osteoarthritis","volume":"45","author":"Rigoglou","year":"2013","journal-title":"Int. J. Biochem. Cel Biol."},{"key":"B49","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1002\/pmic.200700492","article-title":"Urine Protein Profile of IgA Nephropathy Patients May Predict the Response to ACE-Inhibitor Therapy","volume":"8","author":"Rocchetti","year":"2008","journal-title":"Proteomics"},{"key":"B50","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jaad.2016.10.048","article-title":"New Discoveries in the Pathogenesis and Classification of Vitiligo","volume":"77","author":"Rodrigues","year":"2017","journal-title":"J. Am. Acad. Dermatol."},{"key":"B51","doi-asserted-by":"publisher","first-page":"884","DOI":"10.1016\/j.bbapap.2013.06.016","article-title":"Urine as a Source for Clinical Proteome Analysis: from Discovery to Clinical Application","volume":"1844","author":"Rodr\u00edguez-Su\u00e1rez","year":"2014","journal-title":"Biochim. Biophys. Acta (Bba) - Proteins Proteomics"},{"key":"B52","doi-asserted-by":"publisher","first-page":"3906","DOI":"10.1073\/pnas.86.10.3906","article-title":"Corticosterone Differentially Regulates the Expression of Gs Alpha and Gi Alpha Messenger RNA and Protein in Rat Cerebral Cortex","volume":"86","author":"Saito","year":"1989","journal-title":"Proc. Natl. Acad. Sci."},{"key":"B53","doi-asserted-by":"publisher","first-page":"905","DOI":"10.7326\/0003-4819-116-11-905","article-title":"Prediction of Steroid Responsiveness in the Idiopathic Nephrotic Syndrome Using Urinary Retinol-Binding Protein and Beta-2-Microglobulin","volume":"116","author":"Sesso","year":"1992","journal-title":"Ann. Intern. Med."},{"key":"B54","first-page":"14","article-title":"Detection of Plasma and Urinary Monoamines and Their Metabolites in Nonsegmental Vitiligo","volume":"20","author":"Shahin","year":"2012","journal-title":"Acta Dermatovenerol Croat."},{"key":"B55","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1007\/s11427-011-4162-1","article-title":"Applications of Urinary Proteomics in Biomarker Discovery","volume":"54","author":"Shao","year":"2011","journal-title":"Sci. China Life Sci."},{"key":"B56","first-page":"366","article-title":"Proteomics and Melanoma: a Current Perspective","volume":"3","author":"Shields","year":"2016","journal-title":"Glob. Dermatol."},{"key":"B57","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1056\/NEJMcp0804388","article-title":"Vitiligo","volume":"360","author":"Ta\u00efeb","year":"2009","journal-title":"N. Engl. J. Med."},{"key":"B58","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1016\/j.tvjl.2012.01.033","article-title":"Overexpression of P-Glycoprotein, STAT3, Phospho-STAT3 and KIT in Spontaneous Canine Cutaneous Mast Cell Tumours before and after Prednisolone Treatment","volume":"193","author":"Teng","year":"2012","journal-title":"Vet. J."},{"key":"B59","doi-asserted-by":"publisher","first-page":"3787","DOI":"10.2174\/138161206778559777","article-title":"Functional Genome and Proteome Analyses of Cutaneous Autoimmune Diseases","volume":"12","author":"Trcka","year":"2006","journal-title":"Cpd"},{"key":"B60","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1016\/j.lfs.2007.05.006","article-title":"Association of Glutathione S-Transferase Gene Polymorphisms (GSTM1 and GSTT1) of Vitiligo in Korean Population","volume":"81","author":"Uhm","year":"2007","journal-title":"Life Sci."},{"key":"B61","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1186\/s41016-020-00190-5","article-title":"Urinary Biomarker Discovery in Gliomas Using Mass Spectrometry-Based Clinical Proteomics","volume":"6","author":"Wu","year":"2020","journal-title":"Chin. Neurosurg. Jl"},{"key":"B62","doi-asserted-by":"publisher","first-page":"e00530","DOI":"10.1002\/prp2.530","article-title":"Therapeutic Utility of Glucocorticoids and Antihistamines Cotreatment. Rationale and Perspectives","volume":"7","author":"Zappia","year":"2019","journal-title":"Pharmacol. Res. Perspect."},{"key":"B63","doi-asserted-by":"publisher","first-page":"666","DOI":"10.1089\/gtmb.2016.0070","article-title":"Vitamin D-Binding Protein Is a Potential Urinary Biomarker of Irbesartan Treatment Response in Patients with IgA Nephropathy","volume":"20","author":"Zeng","year":"2016","journal-title":"Genet. Test. Mol. biomarkers"}],"container-title":["Frontiers in Molecular Biosciences"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmolb.2022.761562\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,27]],"date-time":"2023-01-27T05:30:25Z","timestamp":1674797425000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmolb.2022.761562\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,2,17]]},"references-count":63,"alternative-id":["10.3389\/fmolb.2022.761562"],"URL":"https:\/\/doi.org\/10.3389\/fmolb.2022.761562","relation":{},"ISSN":["2296-889X"],"issn-type":[{"value":"2296-889X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,2,17]]},"article-number":"761562"}}